VEGFR tyrosine-kinase inhibitor
Fruquintinib (Specialist drug)
Brand names: Fruzaqla
Adult dose
Dose: Specialist initiation only — refer to BNF/SmPC
Route: PO
Frequency: OD
Clinical pearls
- Refractory metastatic colorectal cancer; specialist oncology
Contraindications
- See SmPC
Side effects
- Hypertension
- Hand-foot syndrome
- Proteinuria
- Bleeding
- Thromboembolism
- GI perforation
- Hepatotoxicity
Interactions
- Strong CYP3A4 modulators
- Anticoagulants (bleeding)
Monitoring
- BP
- Urine dipstick
- LFTs
- FBC
Reference: BNF; NICE TA1009; SmPC; https://bnf.nice.org.uk/drugs/fruquintinib-specialist-drug/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Tisdale Risk Score for QT Prolongation · Arrhythmia
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy